Participants 105 130 5
resectable rectal cancer:
Participants 301 486 6
rectal cancer among radiotherapy institutions participating in the framework of a multicentre phase-III European Organization for Research and Treatment of Cancer (EORTC) clinical trial
Participants 488 588 4
Twelve radiotherapy departments with more than 10% of the evaluable patients recruited in the trial,
Participants 930 978 3
5 patients per institution was randomly selected
